1. Home
  2. PCYO vs EMBC Comparison

PCYO vs EMBC Comparison

Compare PCYO & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pure Cycle Corporation

PCYO

Pure Cycle Corporation

HOLD

Current Price

$10.71

Market Cap

249.5M

Sector

Utilities

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.26

Market Cap

200.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCYO
EMBC
Founded
1976
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.5M
200.5M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
PCYO
EMBC
Price
$10.71
$3.26
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
57.1K
2.4M
Earning Date
04-08-2026
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
12.50
20.90
EPS
0.23
0.67
Revenue
$1,227,787.00
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
$47.52
$4.94
Revenue Growth
171.54
N/A
52 Week Low
$9.65
$2.77
52 Week High
$12.44
$15.55

Technical Indicators

Market Signals
Indicator
PCYO
EMBC
Relative Strength Index (RSI) 49.18 39.57
Support Level $10.71 $3.01
Resistance Level $10.96 $3.48
Average True Range (ATR) 0.34 0.18
MACD 0.03 0.14
Stochastic Oscillator 37.96 43.88

Price Performance

Historical Comparison
PCYO
EMBC

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: